Takeda Pharmaceutical
312 hedge funds and large institutions have $1.2B invested in Takeda Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 134 increasing their positions, 65 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 305 → 312 (+7)
2.02% less ownership
Funds ownership: 4.47% → 2.45% (-2%)
Holders
312
Holding in Top 10
–
Calls
$26.6M
Puts
$216K
Top Buyers
| 1 | +$43.9M | |
| 2 | +$35.1M | |
| 3 | +$29.6M | |
| 4 |
BlackRock
New York
|
+$14.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11.1M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$13M | |
| 3 | -$12.7M | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$9.63M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$6.85M |
